The Business Research Company’s Breast Cancer Diagnostics Global Market Report 2021: COVID-19 Impact And Recovery To 2030
LONDON, GREATER LONDON, UK, November 9, 2021 /EINPresswire.com/ — According to the new market research report ‘Breast Cancer Diagnostics Global Market Report 2021: COVID-19 Impact And Recovery’ published by The Business Research Company, the breast cancer diagnostics market is expected to grow from $4.62 billion in 2020 to $5.47 billion in 2021 at a compound annual growth rate (CAGR) of 18.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $7.46 billion in 2025 at a CAGR of 8%. The increasing incidence of breast cancer will require more equipment to diagnose, which will further increase the demand for breast cancer diagnostics market.
Request For A Sample For The Global Breast Cancer Diagnostics Market Report:
The breast cancer diagnostics market consists of sales of breast cancer diagnostic devices and related services by entities (organizations, sole traders and partnerships) that produce breast cancer diagnostics devices. These devices are used to diagnose breast cancer. Only goods and services traded between entities or sold to end consumers are included.
Trends In The Global Breast Cancer Diagnostics Market
The technological advancement is a key trend in the breast cancer diagnostics market. Several new techniques have been developed which could be used in the diagnosis and treatment of breast cancer. The 3D mammography, also known as breast tomosynthesis, takes photographs around the breast from various angles and translates them into a 3-D model. In March 2019, Southwest Medical Center, a US-based company, launched 3D mammography services that provide patients with access to enhanced breast imaging services closer to home.
Global Breast Cancer Diagnostics Market Segments:
The global breast cancer diagnostics market is further segmented:
By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Others
By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
By Cancer Type: BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Others
By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
By End Users: Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
By Geography: The global breast cancer diagnostics market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Breast Cancer Diagnostics Market At:
Breast Cancer Diagnostics Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides breast cancer diagnostics global market overviews, analyzes and forecasts market size and growth for the global breast cancer diagnostics market, breast cancer diagnostics global market share, breast cancer diagnostics global market players, breast cancer diagnostics global market segments and geographies, breast cancer diagnostics global market’s leading competitors’ revenues, profiles and market shares. The breast cancer diagnostics global market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Breast Cancer Diagnostics Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Breast Cancer Diagnostics Market Organizations Covered: Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, C. R. Bard Inc, Gamma Medica Inc, Aurora Imaging Technology Inc, Dilion Technologies Inc, Genomic Health, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc, Leica Biosystems Nussloch GmbH, bioTheranostics Inc, Bio-Rad Laboratories Inc, Illumina Inc, Biocept Inc, Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Here is a list of reports from The Business Research Company similar to the Breast Cancer Diagnostics Global Market Report 2021:
Breast Imaging Devices Global Market Report 2021: COVID-19 Growth And Change
Breast Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change
Breast Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293